Emanuel F. Petricoin III, PhD

University Professor
Co-Director
Center for Applied Proteomics and Molecular Medicine
George Mason University
Fairfax, Virginia
Dr. Emanuel F. Petricoin received his PhD in microbiology from the University of Maryland at College Park. He is a University Professor and the Co-Director of the Center for Applied Proteomics and Molecular Medicine (CAPMM) at George Mason University. The focus of CAPMM is the invention and use of proteomics technologies for personalized therapy, molecular diagnostics, and biomarker discovery. Dr. Petricoin is also the Chief Science Officer and co-founder of Perthera, Inc., a leading precision medicine company that empowers all cancer patients and oncologists globally with the most comprehensive molecular profiling and data analytics process. In addition, he is co-founder of Ceres Nanosciences, Inc., which develops tools for diagnostics and precision medicine applications; Theranostics Health, Inc.; and the Human Proteomic Organization (HUPO). Dr. Petricoin has authored/co-authored nearly 400 peer-reviewed publications and more than 45 book chapters. He is a senior editor for Cancer Epidemiology Biomarkers and Prevention and on the editorial board of JCO Precision Oncology, Proteomics, Biomedical Microdevices, Proteomics-Clinical Applications, Proteomics-Protocols, Molecular, and Carcinogenesis, Journal of Personalized Medicine. Dr. Petricoin is also a co-inventor on 40 filed and published patents.
Last modified: December 9, 2018